Fig. 7From: Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimatesComparison of preclinical vs. clinical PFS fixed effects of ICB therapies. The preclinical (MSR) and clinical (PFS HR) estimates from the meta-analyses for each treatment were plotted against each other (dots) along with their 95% confidence intervals. The red dotted line represents the slope of the regression passing through the origin of the clinical efficacy estimates on the preclinical ones and its 95% confidence interval. The black dotted line represents the perfect correspondence between preclinical and clinical estimates of efficacy. This figure corresponds to the data presented in Table 5Back to article page